AI assistant
Moderna, Inc. — Director's Dealing 2022
Mar 21, 2022
30610_dirs_2022-03-21_79a7f27a-1bd5-42bb-b841-8e7c6888bd0a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2022-03-17
Reporting Person: Hoge Stephen (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-17 | Common Stock | M | 19282 | $151.33 | Acquired | 1630073 | Direct |
| 2022-03-18 | Common Stock | S | 7541 | $171.6659 | Disposed | 1622532 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-17 | Restricted Stock Units | $0 | M | 19282 | Disposed | Common Stock (19282) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4116 | Indirect |
| Common Stock | 151933 | Indirect |
Footnotes
F1: Reflects the date of delivery of RSUs that were scheduled for vesting on February 28, 2022, but for which delivery was delayed until certain antitrust clearance requirements were obtained.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F4: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F5: 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter.